Supriya Lifescience enterprise value

·Pharma & HealthChart ›
MultiplesEnterprise valuePer share
Share price at each year-end
Tap a line for its trendCurrentlast 12MFY25Mar 2025FY24Mar 2024FY23Mar 2023FY22Mar 2022
76.176.168.385.3166
0.00.00.016.621.3
−76.1−76.1−68.3−68.6−144
997997815716637
0.0%0.0%0.0%2.3%3.3%
Reference items — trailing FY values
873————
290————
259————
—16511366.248.8
2.32.3−32.3−42.3−11.1
—16214610859.9
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

SUPRIYA₹869.30

Supriya Lifescience Ltd.

· Pharma & Health
₹ CrorePeersSTARSPARCTHYROCARESHILPAMEDVIYASHRUBICONYATHARTHPARKHOSPS
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY22
31/03/2022
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
Current/LTM
TTM · last close
- Cash, Equiv & ST Investments165.885.368.376.176.1
+ Total Debt21.316.60.00.00.0
Net Debt (memo)-144.5-68.6-68.3-76.1-76.1
Total Capital637.0716.1815.4996.8996.8
Total Debt/Total Capital3.342.320.000.000.00
Reference Items — Trailing FY Values
Sales————872.5
EBITDA————289.8
EBIT————258.9
Operating Cash Flow48.866.2113.3164.7—
Free Cash Flow-11.1-42.3-32.32.32.3
Capital Expenditure59.9108.4145.7162.4—
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY25 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 89%.